Literature DB >> 7030114

Altered development of brain by neonatal ethanol exposure: zinc levels during and after exposure.

H H Samson, J Diaz.   

Abstract

Neonatal rats, exposed to ethanol by use of an artificial rearing technique during the first postnatal week, have been shown to have a 20% reduction in brain weight compared to littermate controls. The mechanisms responsible for this deficit remain to be determined. One hypothesis, which has been suggested that could be responsible for the microcephaly observed in the Fetal Alcohol Syndrome is that human alcoholics have decreased serum zinc levels. It is well documented that zinc deficiency in rats results in microcephaly. Thus, ethanol administered in the diet could result in lowered zinc levels in serum and brain, and hence be the underlying factor for the brain growth deficiency reported. In these studies, serum and brain zinc levels were determined for animals exposed to ethanol using the artificial rearing procedure, and for their littermate controls, artificially reared on the same formula without ethanol. No differences at any time were found in either serum or brain zinc levels. This would suggest that zinc availability could not account for the effects found on brain growth.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030114     DOI: 10.1111/j.1530-0277.1981.tb05362.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  10 in total

Review 1.  Zinc deficiency as a mediator of toxic effects of alcohol abuse.

Authors:  Anatoly V Skalny; Margarita G Skalnaya; Andrei R Grabeklis; Anastasia A Skalnaya; Alexey A Tinkov
Journal:  Eur J Nutr       Date:  2017-11-24       Impact factor: 5.614

2.  Differential expression of proteins in fetal brains of alcohol-treated prenatally C57BL/6 mice: a proteomic investigation.

Authors:  Youssef Sari; Min Zhang; Yehia Mechref
Journal:  Electrophoresis       Date:  2010-01       Impact factor: 3.535

3.  Effects of folic acid and amino acids supplementation on zinc intestinal absorption in the progeny of ethanol-treated rats.

Authors:  E Tavares; O Carreras; A Gómez-Tubío; D Murillo; M L Murillo
Journal:  J Physiol Biochem       Date:  2000-09       Impact factor: 4.158

4.  Alteration of selective neurotransmitters in fetal brains of prenatally alcohol-treated C57BL/6 mice: quantitative analysis using liquid chromatography/tandem mass spectrometry.

Authors:  Youssef Sari; Loubna A Hammad; Marwa M Saleh; George V Rebec; Yehia Mechref
Journal:  Int J Dev Neurosci       Date:  2010-02-01       Impact factor: 2.457

5.  Activity-dependent neuroprotective protein-derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse.

Authors:  Y Sari
Journal:  Neuroscience       Date:  2008-11-21       Impact factor: 3.590

6.  Neurotrophic peptides, ADNF-9 and NAP, prevent alcohol-induced apoptosis at midgestation in fetal brains of C57BL/6 mouse.

Authors:  Youssef Sari; Jason M Weedman; Maxwell Nkrumah-Abrokwah
Journal:  J Mol Neurosci       Date:  2012-11-16       Impact factor: 3.444

7.  A novel peptide, colivelin, prevents alcohol-induced apoptosis in fetal brain of C57BL/6 mice: signaling pathway investigations.

Authors:  Y Sari; T Chiba; M Yamada; G V Rebec; S Aiso
Journal:  Neuroscience       Date:  2009-09-25       Impact factor: 3.590

Review 8.  Fetal alcohol syndrome: the vulnerability of the developing brain and possible mechanisms of damage.

Authors:  J R West; W J Chen; N J Pantazis
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

9.  A Drosophila model for fetal alcohol syndrome disorders: role for the insulin pathway.

Authors:  Kimberly D McClure; Rachael L French; Ulrike Heberlein
Journal:  Dis Model Mech       Date:  2011-02-08       Impact factor: 5.758

Review 10.  A comparison of the different animal models of fetal alcohol spectrum disorders and their use in studying complex behaviors.

Authors:  Anna R Patten; Christine J Fontaine; Brian R Christie
Journal:  Front Pediatr       Date:  2014-09-03       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.